| Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial K Fujitani, HK Yang, J Mizusawa, YW Kim, M Terashima, SU Han, ... The Lancet Oncology 17 (3), 309-318, 2016 | 634 | 2016 |
| Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212 … S Fujita, T Akasu, J Mizusawa, N Saito, Y Kinugasa, Y Kanemitsu, M Ohue, ... The lancet oncology 13 (6), 616-621, 2012 | 362 | 2012 |
| Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority … S Fujita, J Mizusawa, Y Kanemitsu, M Ito, Y Kinugasa, K Komori, M Ohue, ... Annals of surgery 266 (2), 201-207, 2017 | 356 | 2017 |
| Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan … H Katai, J Mizusawa, H Katayama, M Takagi, T Yoshikawa, T Fukagawa, ... Gastric Cancer 20, 699-708, 2017 | 352 | 2017 |
| Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group … S Yamamoto, M Inomata, H Katayama, J Mizusawa, T Etoh, F Konishi, ... Annals of surgery 260 (1), 23-30, 2014 | 330 | 2014 |
| Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis A Tsuburaya, J Mizusawa, Y Tanaka, N Fukushima, A Nashimoto, ... Journal of British Surgery 101 (6), 653-660, 2014 | 324 | 2014 |
| Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma T Sano, M Sasako, J Mizusawa, S Yamamoto, H Katai, T Yoshikawa, ... Annals of surgery 265 (2), 277-283, 2017 | 322 | 2017 |
| Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally … K Nakamura, K Kato, H Igaki, Y Ito, J Mizusawa, N Ando, H Udagawa, ... Japanese journal of clinical oncology 43 (7), 752-755, 2013 | 271 | 2013 |
| Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial S Kitano, M Inomata, J Mizusawa, H Katayama, M Watanabe, ... The lancet Gastroenterology & hepatology 2 (4), 261-268, 2017 | 252 | 2017 |
| Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial C Morizane, T Okusaka, J Mizusawa, H Katayama, M Ueno, M Ikeda, ... Annals of Oncology 30 (12), 1950-1958, 2019 | 218 | 2019 |
| Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a … H Katai, J Mizusawa, H Katayama, S Morita, T Yamada, E Bando, S Ito, ... The lancet Gastroenterology & hepatology 5 (2), 142-151, 2020 | 215 | 2020 |
| Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907 K Kataoka, H Takeuchi, J Mizusawa, H Igaki, S Ozawa, T Abe, ... Annals of surgery 265 (6), 1152-1157, 2017 | 182 | 2017 |
| A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group … N Hasuike, H Ono, N Boku, J Mizusawa, K Takizawa, H Fukuda, I Oda, ... Gastric Cancer 21, 114-123, 2018 | 175 | 2018 |
| High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final … I Miyashiro, M Hiratsuka, M Sasako, T Sano, J Mizusawa, K Nakamura, ... Gastric cancer 17, 316-323, 2014 | 163 | 2014 |
| A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912) K Nakamura, H Katai, J Mizusawa, T Yoshikawa, M Ando, M Terashima, ... Japanese journal of clinical oncology 43 (3), 324-327, 2013 | 154 | 2013 |
| Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the … Japan Clinical Oncology Group (JCOG9502) Kurokawa Y Sasako M msasako@ hyo ... Journal of British Surgery 102 (4), 341-348, 2015 | 152 | 2015 |
| Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma K Minashi, K Nihei, J Mizusawa, K Takizawa, T Yano, Y Ezoe, T Tsuchida, ... Gastroenterology 157 (2), 382-390. e3, 2019 | 148 | 2019 |
| Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase … T Kayama, S Sato, K Sakurada, J Mizusawa, R Nishikawa, Y Narita, ... Journal of Clinical Oncology 36 (33), 3282-3289, 2018 | 135 | 2018 |
| Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial Y Kurokawa, Y Doki, J Mizusawa, M Terashima, H Katai, T Yoshikawa, ... The Lancet Gastroenterology & Hepatology 3 (7), 460-468, 2018 | 131 | 2018 |
| Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated … K Kubota, T Hida, S Ishikura, J Mizusawa, M Nishio, M Kawahara, ... The Lancet Oncology 15 (1), 106-113, 2014 | 127 | 2014 |
